DrugPatentWatch Database Preview
ACCUNEB Drug Patent Profile
Email this page to a colleague
When do Accuneb patents expire, and what generic alternatives are available?
Accuneb is a drug marketed by Mylan Speciality Lp and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has twelve patent family members in eight countries.
The generic ingredient in ACCUNEB is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Accuneb
A generic version of ACCUNEB was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
Summary for ACCUNEB
| International Patents: | 12 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,707 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ACCUNEB |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ACCUNEB |
| DailyMed Link: | ACCUNEB at DailyMed |
Recent Clinical Trials for ACCUNEB
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida |
Paragraph IV (Patent) Challenges for ACCUNEB
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| ACCUNEB | SOLUTION;INHALATION | albuterol sulfate | 020949 | 2005-10-19 |
US Patents and Regulatory Information for ACCUNEB
ACCUNEB is protected by one US patents.
Patents protecting ACCUNEB
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
Patent Number: ⤷ Try it Free
Patent Expiration: ⤷ Try it Free
Patented Use: INDICATED FOR THE RELIEF OF BRONCHOSPASM IN PATIENTS 2-12 YEARS OF AGE WITH ASTHMA (REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | ACCUNEB | albuterol sulfate | SOLUTION;INHALATION | 020949-002 | Apr 30, 2001 | AN | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | |||
| Mylan Speciality Lp | ACCUNEB | albuterol sulfate | SOLUTION;INHALATION | 020949-001 | Apr 30, 2001 | AN | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACCUNEB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | ACCUNEB | albuterol sulfate | SOLUTION;INHALATION | 020949-002 | Apr 30, 2001 | ⤷ Try it Free | ⤷ Try it Free |
| Mylan Speciality Lp | ACCUNEB | albuterol sulfate | SOLUTION;INHALATION | 020949-001 | Apr 30, 2001 | ⤷ Try it Free | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ACCUNEB
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2002347948 | ⤷ Try it Free |
| World Intellectual Property Organization (WIPO) | 03037317 | ⤷ Try it Free |
| New Zealand | 550304 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
